Karboplatin Accord 10 mg/ml koncentrat za otopinu za infuziju clinical trials

Chemoimmunotherapy in conjunction with blood-brain-barrier opening in patients with newly diagnosed or relapsed primary central nervous system lymphoma

This study looks at new ways to treat a rare type of brain lymphoma in adults. It combines chemotherapy with newer immune-boosting drugs. Doctors want to see if this treatment helps patients live longer, whether they are newly diagnosed or if their cancer has returned.